While most GLP-1 shortages resolved in early 2025, regional supply issues can still arise
Maintain hydration and monitor for electrolyte disturbances, especially if gastrointestinal side effects are prominent
If ipamorelin doesnt touch those, it isnt pushing testosterone up at the source
Clinical pathobiochemistry of vitamin B12 deficiency: Improving our understanding by exploring novel mechanisms with a focus on diabetic neuropathy
However, as of the time of this report, Cagrilintide is not approved by the U.S
Therefore, Novo Nordisk does not conclude a causal relationship between GLP-1 RA use, semaglutide and age-related macular degeneration at this time. Dr Alison Cave, the chief safety officer of the Medicines & Healthcare products Regulatory Agency, a UK watchdog, said: Macular degeneration is not currently listed as a potential side-effect of these medicines